Paraoxonase 1 status and interactions between Q192R functional genotypes by smoking contribute significantly to total plasma radical trapping antioxidant potential

Neuroscience Letters

Volumn 581, Issue , 2014, Pages 46-51

  Bortolasci, Chiara Cristina ^a   Maes, Michael ^a,b,c   Vargas, Heber Odebrecht ^a   Souza Nogueira, André ^a   Moreira, Estefania Gastaldello ^a   Nunes, Sandra Odebrecht Vargas ^a   Berk, Michael ^b,d,e,f   Dodd, Seetal ^b,d   Barbosa, Décio Sabbatini ^a  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

^b DEAKIN UNIVERSITY   (Australia)

^c CHULALONGKORN UNIVERSITY   (Thailand)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e ORYGEN RESEARCH CENTRE   (Australia)

^f FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

Body mass index; Depression; Paraoxonase; Psychiatry; Smoking; TRAP

Indexed keywords

ALCOHOL; ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE 1; PSYCHOTROPIC AGENT; TOTAL RADICAL TRAPPING ANTIOXIDANT POTENTIAL; TROLOX C; UNCLASSIFIED DRUG; ARYLDIALKYLPHOSPHATASE; PON1 PROTEIN, HUMAN;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ANTIOXIDANT BLOOD LEVEL; ARTICLE; BIPOLAR DISORDER; BLOOD LEVEL; BODY MASS; CONTROLLED STUDY; DIAGNOSIS RELATED GROUP; DISEASE SEVERITY; EDUCATIONAL STATUS; ENZYME ACTIVITY; ETHNICITY; FEMALE; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HAMILTON SCALE; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MARRIAGE; MOOD DISORDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; SEX DIFFERENCE; SMOKING; TOBACCO DEPENDENCE; ADOLESCENT; DEPRESSION; GENETIC POLYMORPHISM; GENETICS; METABOLISM; MIDDLE AGED; RISK FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIOXIDANTS; ARYLDIALKYLPHOSPHATASE; BIPOLAR DISORDER; BODY MASS INDEX; DEPRESSIVE DISORDER; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; SEX FACTORS; SMOKING; YOUNG ADULT;

EID: 84906771395     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2014.08.020     Document Type: Article

References (33)

1. James R.W., Leviev I., Righetti A. Smoking is associated with reduced serum paraoxonase activity and concentration in patients with coronary artery disease. Circulation 2000, 101(19):2252-2257.
2. Maes M., Galecki P., Chang Y.S., Berk M. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35(3):676-692.
3. Monge M., Ledeme N., Mazouz H., Lalau J., Moubarak M., Presne C., Fournier A., Mazière J.C., Choukroun G., Westeel P.F. Insulin maintains plasma antioxidant capacity at an early phase of kidney transplantation. Nephrol. Dial. Transpl. 2007, 22:1979-1985.
4. Bortolasci C.C., Vargas H.O., Souza-Nogueira A., Barbosa D.S., Moreira E.G., Nunes S.O.V., Berk M., Dodd S., Maes M. Lowered plasma paraoxonase (PON)1 activity is a trait marker of major depression and PON1 Q192R gene polymorphism-smoking interactions differentially predict the odds of major depression and bipolar disorder. J. Affect. Disord. 2014, 159:23-30.
5. Rajkovic M.G., Rumora L., Barisic K. The paraoxonase 1, 2 and 3 in humans. Biochem. Med. 2010, 21(2):122-130.
6. Del Bem C.M., Vilela J.A.A., Crippa J.A.S., Hallak J.E.C., Labate C.M., Zuardi A.W. Confiabilidade da Entrevista Clinica Estruturada para o D.S.M.-IV versão clinica traduzida para o português. Rev. Bras. Psiq. 2001, 23(3):156-159.
7. Moreno R.A., Moreno D.H. Hamilton and montgomery & Asberg depression rating scales. Rev. Psiq. Clin. 1998, 25:262-272.
8. World Health Organization (WHO) Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) Working Group The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility. Addiction 2002, 97:1183-1194.
9. Repetto M., Reides C., Carretero M.L.G. Oxidative stress in blood of HIV infected patients. Clin. Chim. Acta 1996, 255:107-117.
10. Richter R.J., Furlong C.E. Determination of paraoxonas (PON1) status requires more than genotyping. Pharmacogenetics 1999, 9:745-753.
11. Huen K., Richter R.J., Furlong C.E., Eskenazi B., Holland N. Validation of Pon1 enzyme activity assays for longitudinal studies. Clin. Chim. Acta 2009, 402:67-74.
12. Kotani K., Tsuzaki K., Sakane N. Paraoxonase-1 gene Q192R polymorphism and reactive oxygen metabolites. J. Int. Med. Res. 2012, 40:1513-1518.
13. Bonafè M., Marchegiani F., Cardelli M., Olivieri F., Cavallone L., Giovagnetti S., Pieri C., Marra M., Antonicelli R., Troiano L., Gueresi P., Passeri G., Berardelli M., Paolisso G., Barbieri M., Tesei S., Lisa R., De Benedictis G., Franceschi C. Genetic analysis of Paraoxonase (PON1) locus reveals an increased frequency of Arg192 allele in centenarians. Eur. J. Hum. Genet. 2002, 10(5):292-296.
14. Flekac M., Skrha J., Zidkova K., Lacinova Z., Hilgertova J. Paraoxonase 1 gene polymorphisms and enzyme activities in diabetes mellitus. Physiol. Res. 2008, 57:717-726.
15. Solak Z.A., Kabaroglu C., Cok G., Parildar Z., Bayindir U., Ozmen D., Bayindir O. Effect of different levels of cigarette smoking on lipid peroxidation, glutathione enzymes and paraoxonase 1 activity in healthy people. Clin. Exp. Med. 2005, 5:99-105.
16. Vargas H.O., Nunes S.O.V., Barbosa D.S., Vargas M.M., Cestari A., Dodd S., Venugopal K., Maes M., Berk M. Castelli risk indexes 1 and 2 are higher in major depression but other characteristics of the metabolic syndrome are not specific to mood disorders. Life Sci. 2014, 102(1):65-71.
17. Van der Vaart H., Postma D.S., Timens W., ten Hacken N.H. Acute effects of cigarette smoke on inflammation and oxidative stress: a review. Thorax 2004, 59:713-721.
18. Maes M., Kubera M., Uytterhoeven M., Vrydags N., Bosmans E. Increased plasma peroxides as a marker of oxidative stress in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Med. Sci. Monit. 2011, 17(4):11-15.
19. Katalinic V., Modun D., Music I., Boban M. Gender differences in antioxidant capacity of rat tissues determined by 2,2'-azinobis (3-ethylbenzothiazoline 6-sulfonate; ABTS) and ferric reducing antioxidant power (FRAP) assays. Comp. Biochem. Phys. C 2005, 140:47-52.
20. Salminen A., Saari P., Kihlstrom M. Age and sex-related differences in lipid peroxidation of mouse cardiac and skeletal muscles. Comp. Biochem. Phys. 1998, 89:695-699.
21. Chen H.W., Cook L.R., Hendrich S. Gender and dietary fat affect alpha-tocopherol status in F344/N rats. Lipids 1992, 27:844-846.
22. Tiidus P.M., Bombardier E., Hidiroglou N., Madere R. Gender and exercise influence on tissue antioxidant vitamin status in rats. J. Nutr. Sci. Vitaminol. (Tokyo) 1999, 45:701-710.
23. Yagi K., Komura S. Inhibitory effect of female hormones on lipid peroxidation. Biochem. Int. 1986, 13:1051-1055.
24. Sugioka K., Shimosegawa Y., Nakano M. Estrogens as natural antioxidant of membrane phospholipid peroxidation. FEBS Lett. 1987, 210:37-39.
25. Ruiz-Larrea M.B., Leal A.M., Martin C., Martinez R., Lacort M. Antioxidant action of estrogens in rat hepatocytes. Rev. Esp. Fisiol. 1997, 53:225-229.
26. Berk M., Kapczinski F., Andreazza A.C., Dean O.M., Giorlando F., Maes M., Yücel M., Gama C.S., Dodd S., Dean B., Magalhães P.V., Amminger P., McGorry P., Malhi G.S. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci. Biobehav. Rev. 2011, 35(3):804-817.
27. Vargas H.O., Nunes S.O.V., Castro M.R.P., Vargas M.M., Barbosa D.S., Bortolasci C.C., Venugopal K., Dodd S., Berk M. Oxidative stress and inflammatory markers are associated with depression and nicotine dependence. Neurosci. Lett. 2013, 544:136-140.
28. Andreazza A.C., Cassini C., Rosa A.R., Leite M.C., Almeida L.M.V., Nardin P., Cunha A.B., Ceresér K.M., Santin A., Gottfried C., Salvador M., Kapczinski F., Gonçalves C.A. Serum S100B and antioxidant enzymes in bipolar patients. J. Psychiatr. Res. 2007, 41:523-529.
29. Chrysohoou C., Panagiotakos D.B., Pitsavos C., Skoumas I., Papademetriou L., Economou M., Stefanadis C. The implication of obesity on total antioxidant capacity in apparently healthy men and women: the ATTICA study. Nutr. Metab. Cardiovasc. 2007, 17:590-597.
30. Vincent H.K., Taylor A.G. Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int. J. Obes. 2006, 30:400-418.
31. Vicent H.K., Innes K.E., Vicent K.R. Oxidative stress and potential interventions to reduce oxidative stress in overweight and obesity. Diabetes Obes. Metab. 2007, 9:813-839.
32. Palmieri V.O., Grattagliano I., Portincasa P., Palasciano G. Systemic oxidative alterations are associated with visceral adiposity and liver steatosis in patients with metabolic syndrome. J. Nutr. 2006, 136:3022-3026.
33. Halliweell B., Gutteridge J.M.C. Detection of free radicals and other reactive species: trapping and fingerprinting. Free Radicals in Biology and Medicine 1999, 422-425. Oxford Science Publications, New York. 3rd edition.